Enhance your experience at COSM 2025 by visiting with our industry supporters and learning about exciting innovations in Otolaryngology and Head & Neck Surgery at the following events.
COSM does not provide CME credits for the following events, nor does it endorse the views or information presented at these events.
Exhibitor Events
Thursday, May 15 | 6:00 – 8:00 AM
Location: Strand 12 | Breakfast Included
Driving Progress in NNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum
Oncology healthcare professionals (HCPs) face unique challenges in managing head and neck squamous cell carcinoma (HNSCC)—from the complexity of the disease to the need for a multidisciplinary treatment approach. These challenges are exacerbated by the rapid pace of emerging data for new approaches, including expanding the role of immune checkpoint inhibitors. This AMA-accredited program equips HCPs with expert insights and practical strategies to integrate immunotherapy and novel targeted therapies across the HNSCC disease continuum. Stay ahead of evolving treatment paradigms and enhance your ability to deliver effective, team-based care. Provided by Clinical Care Options, LLC. Supported by educational grants from Coherus BioSciences, Inc. and Merck Sharp & Dohme Corp.
Speakers:
Barbara Burtness, MD, Anthony N. Brady Professor of Medicine, Chief Translational Officer, Associate Director, Translational Research, Chief, Head and Neck/Sarcoma Oncology, Co-Leader, Developmental Therapeutics Program, Yale Cancer Center, Yale School of Medicine
Robert Haddad, MD, Division Chief, Head and Neck Oncology, McGraw Chair in Head and Neck Oncology, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School
Cristina Rodriguez, MD, Professor, Division of Hematology/Medical Oncology, Department of Medicine, University of Washington, Member, Fred Hutchinson Cancer Center
Presented by: Clinical Care Options, LLC. Supported by educational grants from Coherus BioSciences, Inc. and Merck Sharp & Dohme Corp.
Innovation Theater Sessions
Location: Elite Hall | Lunch Included | No pre-registration necessary
Thursday, May 15 | 12:00 – 1:00 PM
Co-managing Patients with Advanced Basal Cell Carcinoma (BCC) in an Evolving Treatment Landscape
Speakers: Mahdi Taha, DO, FACOI, FACP Florida Cancer Specialists and Research Institute Boca Raton, FL; John Strasswimmer, MD, PhD, FASLSM Dermatology Associates of the Palm Beaches Palm Beach, FL
Presented by: Regeneron Pharmaceuticals, Inc.
Saturday, May 17 | 12:00 – 1:00 PM
Unlock a Fresh Perspective on CRSwNP: Investigating Epithelial Cytokines
Amgen and AstraZeneca invite you to explore the source of airway inflammation from a fresh perspective! Join us for an expert-led symposium where we will delve into the airway epithelium and the cytokines it can produce, which have been actively investigated as a source of chronic rhinosinusitis with nasal polyps (CRSwNP). Discover emerging data in CRSwNP and how the epithelium can serve as a critical link to CRSwNP.
Speakers: Stella Lee, MD, Director, Brigham Sinus Center Brigham and Women’s Hospital Boston, MA; Christine Franzese, MD Professor of Otolaryngology & Allergy Medical Director University of Missouri Health Care Columbia, MO
Presented by: Amgen/AstraZeneca
